Age related prevalence of severe left ventricular hypertrophy in essential hypertension: Echocardiographic findings from the ETODH study

Blood Pressure

Volumn 21, Issue 3, 2012, Pages 139-145

  Cuspidi, Cesare ^a,b   Meani, Stefano ^c   Sala, Carla ^d   Valerio, Cristiana ^b   Negri, Francesca ^a,b   Mancia, Giuseppe ^a,b,d  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c RHO HOSPITAL   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

echocardiography; elderly; hypertension; severe left ventricular hypertrophy

Indexed keywords

ADULT; AGE; AGED; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; ORGAN INJURY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; ITALY; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 84860880784     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2012.668662     Document Type: Article

References (28)

1. Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J. 2001;141: 334-341. (Pubitemid 32200259)
2. Bombelli M, Facchetti R, Carugo S, Madotto F, Arenare F, Quarti-Trevano F, et al. Left ventricular hypertrophy increases cardiovascular risk independently of in and out-of offi ce blood pressure values. J Hypertens. 2009;27:2458-2464.
3. Tsioufi s C, Vezali E, Tsiachris D, Dimitriadis K, Taxiarchou E, Chatzis D, et al. Left ventricular hypertrophy versus chronic renal disease as predictors of cardiovascular events in hypertension: A Greek 6-year-follow-up study. J Hypertens. 2009;27:1705-1712.
4. Milani RV, Lavie CJ, Mehera MR, Ventura HO, Kartz J D, Messerli F. Left ventricular geometry and survival in patients with normal left ventricular ejection fraction. Am J Cardiol. 2006;97:959-963.
5. Morita H, Larson MG, Barr SC, Vasan RS, O' D onnel CJ, Hirschhorn JN, et al. Single gene mutations and increased wall left ventricular thickness in the community: The Framingham Heart Study. Circulation. 2006;113:2697-2705. (Pubitemid 43947987)
6. Kehat I, Molkentin JD. Molecular pathways underlying cardiac remodeling during pathophysiological stimulation. Circulation. 2010;122:2727-2735.
7. Diez J, Frohlich E. A translational approach to hypertensive heart disease. Hypertension. 2010;55:1-8.
8. Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP. Echocardiographic criteria for left ventricular hypertrophy: The Framingham Heart Study. Am J Cardiol. 1987;59:956-960. (Pubitemid 17074242)
9. Ruilope LM, Schmieder RE. Left ventricular hypertrophy and clinical outcomes in hypertensive patients. Am J Hypertens. 2008;21:500-506.
10. Wachtell K, Bella JN, Liebson P, Gerdts E, Dahlof B, Aalto T, et al. Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population. The LIFE Study. Hypertension. 2000;35:6-12. (Pubitemid 30054229)
11. Cuspidi C., Ambrosioni E, Mancia G, Pessina AC, Trimarco B, Zanchetti A. Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: The Assessment of Prognostic Risk Observational Survey. J Hypertens. 2002;20:1307-1314. (Pubitemid 34925675)
12. Mancia G, Carugo S, Grassi G, Lanzarotti A, Schiavina R, Cesana G, Sega R. Prevalence of left ventricular hypertrophy in hypertensive patients without and with blood pressure control: Data from the PAMELA population. Hypertension. 2002;39: 744-749. (Pubitemid 34252868)
13. Glorioso N, Filigheddu F, Pinna Parpaglia P, Soro A, Troffa C, Argiolas G, Mulatero P. 11beta-hydroxysteroid dehydrogenase type 2 activity is associated with left ventricular mass in essential hypertension. Eur Heart J. 2005;26:498-504. (Pubitemid 40314766)
14. Cuspidi C, Meani S, Valerio C, Sala C, Fusi V, Zanchetti A, Mancia G. Age and target organ damage in essential hypertension: Role of the metabolic syndrome. Am J Hypertens. 2007;20:296-303. (Pubitemid 46283362)
15. Devereux RB, Reickek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977;55:613-618. (Pubitemid 8066109)
16. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Chamber Quantifi cation Writing Group; American Society of Echocardiography ' s Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantifi cation: A report from the American Society of Echocardiography ' s Guidelines and Chamber Quantifi cation Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-63.
17. 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007: 25:1105-1187.
18. Pignoli P, Tremoli E, Poli A, Paoletti R. Intimal plus media thickness of the arterial wall: A direct measurement with ultrasound imaging. Circulation. 1986;74:1399-1408.
19. Cuspidi C, Lonati L, Macca G, Sampieri L, Fusi V, Michev I, et al. Prevalence of left ventricular hypertrophy and carotid thickening in a large selected population: Impact of different echocardiographic and ultrasonographic diagnostic criteria. Blood Press. 2001;10:142-149. (Pubitemid 32982494)
20. Cuspidi C, Meani S, Salerno M, Fusi V, Severgnini B, Valerio C, et al. Retinal microvascular changes and target organ damage in untreated essential hypertensives. J Hypertens. 2004;22: 2095-2102. (Pubitemid 39463801)
21. Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Pal ù C, et al. Risk factors associated with alterations in carotid intima-media thickness in hypertension: Baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens. 1998;16:949-961.
22. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung and Blood Institute Scientifi c Statement. Circulation. 2005;112:1-18.
23. de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh J. Effect of growth on variability of left ventricular mass: Assessment of allometric signals in adults and children and their predictive capacity to predict cardiovascular risk. J Am Coll Cardiol. 1995;25:1056-1062.
24. Cuspidi C, Mancia G, Ambrosioni E, Pessina A, Trimarco B, Zanchetti A. Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: Results from the Assessment Prognostic Risk Observational Survey (APROS). J Hum Hypertens. 2004;18:891-896. (Pubitemid 39600145)
25. Zanchetti A, Cuspidi C, Comarella L, Agabiti-Rosei E, Ambrosioni E, Chiarello M, et al. Left ventricular diastolic dysfunction in elderly hypertensives: Results of the APROSdiadys study. J Hypertens. 2007;25:2158-2167. (Pubitemid 47476315)
26. Wild PS, Sinning CR, Roth A, Wilde S, Schnabel RB, Lubos E, et al. Distribution and categorization of left ventricular measurements in the general population. Results from the population-based Gutenberg heart study. Circ Cardiovasc Imaging. 2010;3:604-613.
27. Cuspidi C, Negri F, Muiesan L, Capra A, Lonati L, Milan A, et al. Prevalence and severity of echocardiographic left ventricular hypertrophy in clinical practice. Blood Press. 2010;20:3-9.
28. Palatini P, Mos L, Santonastaso M, Saladini F, Benetti E, Mormino P, et al. Premenopausal women have increased risk of hypertensive target organ damage compared with men of similar age. J Womens Health. 2011;20:1175-1181.